ChatGPT vs Claude for Healthcare Compliance Officers
Side-by-side comparison of ChatGPT and Claude for medical device compliance workflows — QSR + GMLP documentation gap audits, PCCP scope assessment, MedWatch reportability triage, and 510(k) Substantial Equivalence evidence mapping.
Healthcare compliance for AI-enabled medical devices is the highest-stakes profession in the entire AI compliance ecosystem. The FDA's January 2026 post-market shift moved weight from premarket review to post-market surveillance, PCCP authorization, and GMLP alignment. 21 CFR 803 Medical Device Reporting obligations remain unforgiving: missing a reportable adverse event has both severe regulatory consequences and — far more importantly — direct patient-safety consequences. The model decision matters because a confident-sounding LLM that produces "not reportable" conclusions is exactly the wrong tool; the model that defaults to "escalate to MDR coordinator" framing is the only acceptable pattern.
We tested both ChatGPT and Claude across the four workflows that come up in every healthcare compliance officer's week: QSR + GMLP documentation gap audit with Subpart-level specificity, PCCP scope assessment per the December 2024 final guidance, MedWatch reportability triage with §803.50 factor analysis, and 510(k) Substantial Equivalence evidence mapping.
This comparison focuses on what working healthcare compliance officers actually care about in 2026: refusal to produce reportability decisions or Substantial Equivalence arguments (the patient-safety and submission-quality consequences of getting these wrong are severe), correct regulatory citations (21 CFR sections by Subpart, GMLP principles by name, IEC/ISO standards by number), PHI-handling discipline, and how directly the output flows into the eQMS / MDR / submission systems without bypassing qualified personnel.
Side-by-Side Comparison
| Category | ChatGPT | Claude | Verdict |
|---|---|---|---|
| Refusal to Produce Reportability Decisions | Will produce reportability conclusions if asked, even when the appropriate response is escalation. Improves significantly with 'never produce not-reportable conclusions' instructions but defaults to confident framing. | More conservative by default. More likely to surface factors pointing toward and away from reportability rather than producing a conclusion. Better aligned with the escalate-to-MDR-coordinator pattern this profession requires. | Claude |
| 21 CFR Citation Specificity | Knows the major 21 CFR sections. May produce generic 'reportable under 21 CFR 803' framing rather than the specific §803.50(a)(1) / §803.50(a)(2) / §803.3 (serious injury definition) granularity. | More consistent at producing section-specific citations by default. Better fit for outputs that go into MDR coordination workflows where the specific section matters. | Claude |
| GMLP Principle-by-Principle Discipline | Aware of GMLP. May default to aggregate alignment assessment rather than walking through each of the 10 principles with evidence and gaps. | More consistent at producing principle-by-principle alignment notes by default. Better fit for gap audits that QA can act on. | Claude |
| PCCP 3-Section Framework Fidelity | Recognizes the three PCCP sections (Description of Modifications / Modification Protocol / Impact Assessment). May produce gestalt scope conclusions rather than per-section analysis. | More consistent at producing per-section analysis against each PCCP element. Better fit for scope assessments that drive submission-pathway decisions. | Claude |
| PHI Handling Discipline | Generally respects PHI when explicitly instructed to strip identifying details. May default to including identifying-feeling placeholders (specific names, dates) in synthetic examples. | More conservative about PHI by default. More likely to flag identifying details that have crept into inputs and recommend de-identification before continuing. | Claude |
| Substantial Equivalence Argument Framing | Will produce SE arguments if asked, sometimes without the framing that the actual argument requires regulatory affairs and clinical leadership review. | More consistent at framing SE outputs as 'evidence mapping for the regulatory affairs lead' rather than final SE arguments. Better aligned with the preparatory-analysis pattern. | Claude |
| Subgroup Performance Surfacing | Recognizes subgroup performance as an FDA review attention area when prompted. May not consistently surface it as a P0 gap-audit dimension without explicit instruction. | More consistent at flagging subgroup performance (demographic and clinically-relevant strata) as a P0 review attention area by default. Better fit for AI/ML SaMD work specifically. | Claude |
| Cost | Free tier available. Plus at $20/month. Team at $25/user/month. Pricing reflects what's published on openai.com at the time of writing; verify current pricing. | Free tier available. Pro at $20/month. Team at $25/user/month. Pricing reflects what's published on anthropic.com at the time of writing; verify current pricing. | Tie |
Refusal to Produce Reportability Decisions
ClaudeChatGPT
Will produce reportability conclusions if asked, even when the appropriate response is escalation. Improves significantly with 'never produce not-reportable conclusions' instructions but defaults to confident framing.
Claude
More conservative by default. More likely to surface factors pointing toward and away from reportability rather than producing a conclusion. Better aligned with the escalate-to-MDR-coordinator pattern this profession requires.
21 CFR Citation Specificity
ClaudeChatGPT
Knows the major 21 CFR sections. May produce generic 'reportable under 21 CFR 803' framing rather than the specific §803.50(a)(1) / §803.50(a)(2) / §803.3 (serious injury definition) granularity.
Claude
More consistent at producing section-specific citations by default. Better fit for outputs that go into MDR coordination workflows where the specific section matters.
GMLP Principle-by-Principle Discipline
ClaudeChatGPT
Aware of GMLP. May default to aggregate alignment assessment rather than walking through each of the 10 principles with evidence and gaps.
Claude
More consistent at producing principle-by-principle alignment notes by default. Better fit for gap audits that QA can act on.
PCCP 3-Section Framework Fidelity
ClaudeChatGPT
Recognizes the three PCCP sections (Description of Modifications / Modification Protocol / Impact Assessment). May produce gestalt scope conclusions rather than per-section analysis.
Claude
More consistent at producing per-section analysis against each PCCP element. Better fit for scope assessments that drive submission-pathway decisions.
PHI Handling Discipline
ClaudeChatGPT
Generally respects PHI when explicitly instructed to strip identifying details. May default to including identifying-feeling placeholders (specific names, dates) in synthetic examples.
Claude
More conservative about PHI by default. More likely to flag identifying details that have crept into inputs and recommend de-identification before continuing.
Substantial Equivalence Argument Framing
ClaudeChatGPT
Will produce SE arguments if asked, sometimes without the framing that the actual argument requires regulatory affairs and clinical leadership review.
Claude
More consistent at framing SE outputs as 'evidence mapping for the regulatory affairs lead' rather than final SE arguments. Better aligned with the preparatory-analysis pattern.
Subgroup Performance Surfacing
ClaudeChatGPT
Recognizes subgroup performance as an FDA review attention area when prompted. May not consistently surface it as a P0 gap-audit dimension without explicit instruction.
Claude
More consistent at flagging subgroup performance (demographic and clinically-relevant strata) as a P0 review attention area by default. Better fit for AI/ML SaMD work specifically.
Cost
TieChatGPT
Free tier available. Plus at $20/month. Team at $25/user/month. Pricing reflects what's published on openai.com at the time of writing; verify current pricing.
Claude
Free tier available. Pro at $20/month. Team at $25/user/month. Pricing reflects what's published on anthropic.com at the time of writing; verify current pricing.
Our Recommendation
For healthcare compliance officers working on AI-enabled medical devices, Claude is the better default for the structured-analysis work — QSR + GMLP gap audits with Subpart and principle-by-principle specificity, PCCP scope assessment with per-section analysis, MedWatch reportability triage that errs toward escalation, and 510(k) evidence mapping with Q-Sub preparation. The discipline around refusing to produce reportability decisions matters more in this profession than almost any other — the patient-safety consequences of an under-reported adverse event are direct, immediate, and irreversible.
ChatGPT remains useful for short-form internal communication — exec briefs, peer-team explanations of regulatory shifts, internal incident summaries. Many working healthcare compliance officers in 2026 use both: Claude for the artifacts that go to QA, the MDR coordinator, regulatory affairs, and FDA submission packages; ChatGPT for the short-form internal communication where speed matters more than the strict pre-determination framing.
The most impactful unlock — independent of which model you use — is anchoring every session to your quality manual, your current SOPs, the applicable FDA guidance, and (critically) the explicit instruction that the model NEVER produces reportability decisions or SE arguments. Without that anchoring, outputs drift toward confident-sounding conclusions that don't fit the work. Start with the QSR + GMLP Documentation Gap Audit, then add PCCP Scope Audit, MedWatch Reportability Triage, and 510(k) Evidence Mapping as each phase of your device lifecycle comes up. And when in doubt about reportability, escalate.
Related Tools from The AI Career Lab
Skip the prompt engineering. These purpose-built tools produce professionally formatted documents in seconds.
QSR + GMLP Documentation Gap Audit
Audit AI-enabled medical device documentation against FDA 21 CFR 820 (QSR/QMSR) Subparts, GMLP guiding principles, and the January 2026 post-market expectations. P0/P1/P2 ranked gap report. Preparatory analysis for QA, regulatory affairs, and clinical leadership — not a compliance opinion.
PCCP Scope Audit
Analyze whether a proposed AI medical device modification fits an existing Predetermined Change Control Plan (per the December 2024 FDA final guidance), requires a PCCP amendment, or triggers a new 510(k) / De Novo / PMA submission. Preparatory analysis for regulatory affairs — not a submission-pathway determination.
MedWatch Reportability Triage
Triage potential adverse events for 21 CFR 803 reportability with §803.50 factors, 3500A framing, and escalation questions for the MDR coordinator. The MDR coordinator — not this tool — makes the reportability determination. When in doubt, escalate.
510(k) Evidence Mapping
Map clinical evidence and performance data to the FDA Substantial Equivalence framework for a 510(k) submission. Includes intended-use comparison, side-by-side technological characteristics, evidence gaps, and Q-Sub preparation topics. Preparatory analysis for regulatory affairs — not a Substantial Equivalence argument.